Top-News

Illumina Aktie News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
109,76 €
-0,1 €
-0,09%
09:13:12 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,44 Mrd. €
Streubesitz
-
KGV
-17,49
neu: Nachhaltigkeits-Score
50 %
Index-Zuordnung
Nasdaq Composite Index
Weiter abwärts? Short handeln - Jetzt mit Hebel 9,48: JZ0YK8
Werbung

Illumina News

23.06.25 - PR Newswire
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy PR Newswire
10.06.25 - wallstreetONLINE Redaktion
Aktie vor Turnaround?: Keine Geduld mehr mit Bayer und Evotec? Diese Aktie könnte die Lösung sein!
Turnaround-​Wetten kosten viel Zeit, Nerven – und oft auch Geld. Vor allem Evotec und Bayer enttäuschten zuletzt immer wieder. Deutlich aussichtsreicher könnte jetzt Gen- und ...
10.06.25 - PR Newswire
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics PR Newswire
10.06.25 - inv3st.de
Zukunftsmarkt - hier geht es um 50 Mrd. USD: Illumina, Moderna, PanGenomic Health
Medizin wird persönlich. Die Zeit, in der Medikamente allen helfen sollen, naht ihrem Ende. Die Experten von BCC Research gehen davon aus, dass der Markt für personalisierte ...
28.05.25 - PR Newswire
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies PR Newswire
14.05.25 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
13.05.25 - PR Newswire
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications PR Newswire
08.05.25 - PR Newswire
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 PR Newswire
01.05.25 - PR Newswire
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
Illumina and Ovation.io launching first-​of-kind GLP-1 dataset to accelerate new therapy development PR Newswire
15.04.25 - PR Newswire
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation PR Newswire
10.04.25 - PR Newswire
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 PR Newswire
25.03.25 - PR Newswire
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors PR Newswire
19.03.25 - PR Newswire
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery PR Newswire
10.03.25 - PR Newswire
Illumina addresses recent developments in China
Illumina addresses recent developments in China PR Newswire
06.03.25 - PR Newswire
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Illumina named to Dow Jones Best-​in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year PR Newswire
24.02.25 - PR Newswire
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology PR Newswire
21.02.25 - PR Newswire
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-​cell solutions PR Newswire
19.02.25 - PR Newswire
Illumina unveils first-of-its-kind spatial transcriptomics technology
Illumina unveils first-​of-its-kind spatial transcriptomics technology PR Newswire
18.02.25 - PR Newswire
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference PR Newswire
06.02.25 - PR Newswire
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024 PR Newswire

Newssuche

Videos

newspaper
02.12.25 +8,18%
Technical Trading: DAX Long dienstags
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »